Clinical trial
Targeting the Gut to Improve Seizure Control in CDD
NCT06448663 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting the Gut to Improve Seizure Control in CDD
- Lead sponsor
- University of Milan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2024
- Completion date
- April 30, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cdkl5